Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study

Anton Hagenbeek, MD PhD, Josée M Zijlstra, MD, Wouter J Plattel, MD, Franck Morschhauser, MD, Petronella J Lugtenburg, MD PhD, Pauline Brice, MD, Martin Hutchings, MD, Thomas Gastinne, MD, Roberto D Liu, Coreline N Burggraaf, MD, Marcel Nijland, MD, Sanne H Tonino, MD PhD, Harm van Tinteren, MSc, Marta I Lopez Yurda, MSc, Marie José Kersten, MD PhD

Blood (2018) 132 (Supplement 1): 2923.

https://doi.org/10.1182/blood-2018-99-112235

Published: 2018

Journal Articles

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

Iris de Weerdt, Sanne Terpstra, Tom Hofland, Roeland Lameris, MD, Renee C.G. de Bruin, Mark-David Levin, MDPhD, Ester B.M. Remmerswaal, PhD, Ineke J.M. ten Berge, MD PhD, Sanne H. Tonino, MD PhD, Tanja D de Gruijl, PhD, Hans van der Vliet, MD PhD, Arnon P. Kater, MD PhD

Blood (2015) 126 (23): 2914.

https://doi.org/10.1182/blood.V126.23.2914.2914

Published: 2015

Journal Articles

EBV-Specific CD8 + T-Cells Are Not Functionally Impaired in Chronic Lymphocytic Leukemia

Tom Hofland, Iris de Weerdt, Sanne Terpstra, Ester B.M. Remmerswaal, PhD, Ineke J.M. ten Berge, MD PhD, Arnon P. Kater, MD PhD, Sanne H. Tonino, MD PhD

Blood (2015) 126 (23): 1723.

https://doi.org/10.1182/blood.V126.23.1723.1723

Published: 2015

Journal Articles

Interim Analysis Of Dose-Escalation Stage Of a Phase 1b Study Evaluating Safety and Pharmacology Of GS-9820, a Second-Generation, Selective, PI3Kd-Inhibitor in Recurrent Lymphoid Malignancies

Arnon P. Kater, MD PhD, Sanne H. Tonino, MD, PhD, Marie Jose Kersten, MD, PhD, Anton Hagenbeek, MD, PhD, Marjolein Spiering, Msc, Marinus H van Oers, MD PhD, Yan Xin, PhD, Srinivasan Ramanathan, PhD, Maria Aiello, MA, Susie Jun, MD, PhD

Blood (2013) 122 (21): 2881.

https://doi.org/10.1182/blood.V122.21.2881.2881

Published: 2013

Journal Articles

CMV-Specific CD8 + T-CELL Function Is NOT Impaired In CLL

Doreen te Raa, MD, Fernanda Pascutti, PhD, Juan J Garcia-Vallejo, PhD, Emilie Reinen, Ester B.M. Remmerswaal, René A.W. Van Lier, PhD, Eric Eldering, PhD, Marinus H.J. Van Oers, MD, PhD, Sanne H. Tonino, MD PhD, Arnon P. Kater, MD PhD

Blood (2013) 122 (21): 2862.

https://doi.org/10.1182/blood.V122.21.2862.2862

Published: 2013

Journal Articles

Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.

Sanne H. Tonino, MD, Chantal Mulkens, Yoshinori Nonomura, MD, Guangli Suo, MD, Thomas J. Kipps, MD, PhD, Marinus H.J. van Oers, MD, PhD, Eric Eldering, MD, Arnon P. Kater, MD, PhD

Blood (2008) 112 (11): 2102.

https://doi.org/10.1182/blood.V112.11.2102.2102

Published: 2008

Journal Articles

CMV-Associated Expansion of CD8 + CD45RA + CD27 − T-Cells in Patients with B-Cell Malignancies.

Sanne H. Tonino, MD, Marinus H.J. Van Oers, MD, PhD, Rene A. Van Lier, MD, PhD, Marie Jose Kersten, MD, PhD

Blood (2007) 110 (11): 3592.

https://doi.org/10.1182/blood.V110.11.3592.3592

Published: 2007

Journal Articles

CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.

Sanne H. Tonino, MD, Rene Spijker, Marinus H.J. Van Oers, MD, PhD, Arnon P. Kater, MD, PhD

Blood (2007) 110 (11): 1139.

https://doi.org/10.1182/blood.V110.11.1139.1139

Published: 2007

NARROW

Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

EBV-Specific CD8 + T-Cells Are Not Functionally Impaired in Chronic Lymphocytic Leukemia

Interim Analysis Of Dose-Escalation Stage Of a Phase 1b Study Evaluating Safety and Pharmacology Of GS-9820, a Second-Generation, Selective, PI3Kd-Inhibitor in Recurrent Lymphoid Malignancies

CMV-Specific CD8 + T-CELL Function Is NOT Impaired In CLL

Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.

CMV-Associated Expansion of CD8 + CD45RA + CD27 − T-Cells in Patients with B-Cell Malignancies.

CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only